Childhood cancer research receives approximately 4% of the National Cancer Institute's budget. Less common cancers, such as DMG/DIPG, receive an extremely small portion of that 4%.
Current funding for research comes primarily from private foundations and academic institutions. With very few exceptions, the for-profit pharmaceutical industry does not invest its resources in pediatric brain cancer. There has never been a drug developed for pediatric brain cancer.
Current Federal Legislative Efforts
The following Legislative initiatives are current efforts.
Head to the Hill event in 2019, the last year the advocacy event was held in person.
